Tag: Health Costs
Research & Development Investments Do Not Explain Drug Price Variation
No association seen between estimated R&D investments and treatment costs based on list prices at launch or net prices after one year
Medical Debt Tied to Worsening of Food, Housing Insecurity
Risk factors for medical indebtedness include hospitalization, disability, high deductible, Medicare Advantage, and no insurance coverage
OOP Costs Seen for Some Seeking Emergency Care After Sexual Assault
Average emergency department charges were $3,551; charges for victims of sexual abuse highest during pregnancy
OOP Costs for Cancer Treatments Increased From 2009 to 2016
Total costs increased for breast, lung, prostate cancer; OOP costs increased for these cancers and colorectal cancer
Peritoneal Dialysis Less Costly for Medicare Than Hemodialysis
Convergence in the costs of intravenous dialysis drugs seen between peritoneal dialysis, hemodialysis
Out-of-Pocket Costs for Naloxone Up for Uninsured Patients
For 2018 compared with 2014, mean out-of-pocket cost of naloxone increased by 506 percent among uninsured patients
How Will New Federal Legislation Cut Drug Costs?
Under the law, Medicare will now be allowed to negotiate the cost of some drugs; vaccines will be free for Part D recipients
Burden of Disease Attributed to PFAS Exposure High in the U.S.
Estimated cost of PFAS-attributable disease at least $5.52 billion annually
Poll: Inflation Has Many Americans Cutting Back on Health Care
One in four Americans have put off medical care or prescription purchases due to higher prices
Burden of Disease Attributed to PFAS Exposure High in the U.S.
Estimated cost of PFAS-attributable disease at least $5.52 billion annually
